Becton Dickinson and Co vs Marvell Technology Inc — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while Marvell Technology Inc trades at $220.25 (market cap $190.56B). The key difference: Marvell Technology Inc is far larger — about 3.9× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays the higher dividend (2.32%). Which is the better fit depends on your goals.
| BDX | MRVL | |
|---|---|---|
Market Cap | $49.41B | $190.56B |
Sector | Health | Technology |
52-Week High | $185.39 | $316.43 |
52-Week Low | $138.62 | $62.31 |
Enterprise Value | $65.51B | $191.99B |
Dividend Yield | 2.32% | 0.11% |
Trailing returns across standard periods
Latest headlines on both assets
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →